NEVRARGENICS
NEVRARGENICS
Social Links:
Founded:
2019-01-01
Address:
Durham, Durham, United Kingdom
Country:
United Kingdom
Website Url:
http://www.rar-mtherapeutics.co.uk
Total Employee:
1+
Status:
Active
Similar Organizations
Nanovector
Nanovector is a pharmaceutical company.
Tecnifar
Tecnifar is a pharmaceutical company.
Current Employees Featured
Official Site Inspections
http://www.rar-mtherapeutics.co.uk
Unable to get host informations!!!
More informations about "Nevrargenics"
NEVRARGENICS LIMITED - Companies House
RAR-M THERAPEUTICS LIMITED 18 Dec 2019 - 10 Nov 2020 Tell us what you think of this service (link opens a new window) Is there anything wrong with this page? (link opens a new …See details»
Nevrargenics - novel drugs for neurodegenerative diseases
Our strategy is to employ new dual-acting retinoic acid receptor modulators (RAR-M) as the basis for developing a series of new rationally designed, effective treatments, meeting that most …See details»
Nevrargenics Company Profile 2024: Valuation, Funding
Operator of a neuroscience company intended to discover and develop novel medicines for the treatment of neurodegenerative disease. The company offers treatment for Alzheimer's …See details»
About RAREi | The Canadian Forum for Rare Disease Innovators …
RAREi is an informal network of Canadian research-based bio-pharmaceutical organizations involved in developing therapeutics for rare diseases. The purpose of RAREi is to provide a …See details»
RAR-M Therapeutics - Facebook
Jan 21, 2020 · RAR-M Therapeutics. 26 likes. RAR-M is developing neurodegenerative disease drugs, particularly for tackling ALSSee details»
National Organization for Rare Disorders | NORD
3 days ago · NORD® Rare Disease Centers of Excellence are diagnosing and treating thousands of rare disease patients. Assist researchers throughout the world better understand and treat …See details»
Therapies for rare diseases: therapeutic modalities, progress and ...
Dec 13, 2019 · With this in mind, we discuss here the technological basis and rare disease applicability of the main therapeutic modalities, including small molecules, monoclonal …See details»
Precision Neuroscience, Transformational Therapies | Engrail
Engrail Therapeutics is a clinical-stage pharmaceutical company founded in 2019 with the aspiration of becoming a leader in neuroscience. We are committed to rapidly advancing our …See details»
Rar-mtherapeutics : rar-mtherapeutics.com
Rar-mtherapeutics.com is 4 years 5 months old. It is a domain having com extension. This website is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats …See details»
HOME | pHion Therapeutics | Belfast
PHion Therapeutics is a UK based biotech delivering ground-breaking nucleic acid vaccines and therapeutics. The proprietary RALA peptide-based drug delivery system is based on a …See details»
Unlocking the promise of mRNA therapeutics - Nature
Nov 3, 2022 · Early clinical trials of mRNA therapeutics include studies of paracrine vascular endothelial growth factor (VEGF) mRNA for heart failure and of CRISPR–Cas9 mRNA for a …See details»
Lam Therapeutics - VentureRadar
LAM Therapeutics develops precision therapeutics and companion diagnostics for cancer and rare diseases. LAM accelerates drug development by deploying technologies including next …See details»
Retinoic Acid Pathway Therapeutics Market Projected to Reach
2 days ago · InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Hydrogen Valve Market - (By Valve Type (Needle Valve, Ball Valve, Check …See details»
RAR and RXR modulation in cancer and metabolic disease
Retinoic acid receptors (RARs) are ligand-controlled transcription factors that form heterodimers with rexinoid X receptors (RXRs) to regulate many physiological processes, such as embryo...See details»
Nutcracker Therapeutics Presents Precision Biomanufacturing and …
2 days ago · EMERYVILLE, Calif., November 26, 2024--(BUSINESS WIRE)--Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA …See details»
Retinoid Receptors and Therapeutic Applications of RAR/RXR …
Retinoic acid receptors (RARs) are ligand-controlled transcription factors that function as heterodimers with retinoid X receptors (RXRs) to regulate cell growth, differentiation, survival …See details»
Nutcracker Therapeutics Presents Precision Biomanufacturing and …
3 days ago · About Nutcracker Therapeutics, Inc. Nutcracker Therapeutics, Inc. is a biotechnology CRDMO company that combines advanced engineering with high-precision biosynthesis to …See details»
Lanchi Ventures Leads $42M Series A Financing for Allink ...
4 hours ago · The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. BEIJING, Nov. …See details»
A PML/RARα direct target atlas redefines transcriptional …
Mar 18, 2021 · PML/RARα activates target gene GFI1 through chromatin conformation at the super-enhancer region, which is required for APL cell growth. Transcriptional deregulation …See details»
Retinoic acid receptor γ is a therapeutically targetable driver of ...
Sep 3, 2020 · There are three isotypes of RARs (RARα, RARβ, and RARγ) and recent studies have revealed discrete physiological roles. For example, RARα and RARγ promote …See details»